Expertise in
24
conditions

Dr. Shannon B. Keating

Hematology | Oncology
Broward Health Physician Group
1625 SE 3rd Ave Ste 525, 
Fort Lauderdale, FL 
Accepting New Patients
Offers Telehealth
Expertise in
24
conditions
Broward Health Physician Group
1625 SE 3rd Ave Ste 525, 
Fort Lauderdale, FL 

Overview

Shannon Keating is a Hematologist and an Oncologist practicing medicine in Fort Lauderdale, Florida.

Dr. Keating is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Breast Cancer, Paget Disease of the Breast, and Thalassemia.

She is actively involved in clinical research, participating in 5 clinical trials. Dr. Keating is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Hospitalist in FL

Hospital Affiliations

Broward Health Medical Center
Broward Health Imperial Point
Broward Health North

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Broward Health Physician Group
1625 SE 3rd Ave Ste 525, Fort Lauderdale, FL 33316

Additional Areas of Focus

Dr. Keating has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: May 29, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
13
conditions
Dr. Craig H. Moskowitz
Oncology | Hematology
Expertise in
13
conditions
Dr. Craig H. Moskowitz
Oncology | Hematology
Referral may be required
5555 Ponce De Leon Boulevard, Floor 4, 
Coral Gables, FL 
 (28.4 miles away)
305-243-5302
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Craig Moskowitz is an Oncologist and a Hematologist practicing medicine in Coral Gables, Florida. Dr. Moskowitz is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Moskowitz is currently accepting new patients.

Expertise in
74
conditions
Dr. Warren S. Brenner
Hematology | Oncology
Expertise in
74
conditions
Dr. Warren S. Brenner
Hematology | Oncology
Referral may be required

Baptist Health Lynn Cancer Institute | Boca Raton

701 NW 13th St, 
Boca Raton, FL 
 (18.2 miles away)
561-639-8831
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Warren Brenner is a Hematologist and an Oncologist practicing medicine in Boca Raton, Florida. Dr. Brenner is highly rated in 74 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), and Familial Colorectal Cancer. Dr. Brenner is currently accepting new patients.

Expertise in
11
conditions
Dr. Jose Lutzky
Hematology | Oncology
Expertise in
11
conditions
Dr. Jose Lutzky
Hematology | Oncology
Referral may be required
2111 Sole Mia Way 5th, 
Miami, FL 
 (14.0 miles away)
Languages Spoken:
English, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jose Lutzky, M.D., is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Lutzky works as part of a multidisciplinary team of cancer experts and researchers. He earned his medical degree from Universidade Federal do Rio Grande do Sul. Dr. Lutzky is fluent in Spanish and Portuguese and his career highlights include: Recognized for his expertise in melanoma, basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma. Triple board certified in hematology, oncology and internal medicine Completed his residency in internal medicine at Mount Sinai Medical Center in Miami Beach, Florida Fellowship in hematology/oncology at Columbia Universitys New York-Presbyterian Hospital Extensive clinical research experience and interests Authored numerous articles and abstracts Fellow of the American College of Physicians. Dr. Lutzky is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma. Dr. Lutzky is currently accepting new patients.

Frequently Asked Questions about Dr. Shannon B. Keating

How do I make an appointment with Dr. Shannon B. Keating?

You can book an appointment with Dr. Shannon B. Keating by calling their office at 954-355-4975. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shannon B. Keating a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shannon B. Keating is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shannon B. Keating specialize in?

While Dr. Shannon B. Keating is a Hematology, they have specific expertise in Multiple Myeloma, Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Shannon B. Keating accept my insurance?

Dr. Shannon B. Keating accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 954-355-4975 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Keating's expertise for a condition
ConditionClose
      View All 24 Advanced Conditions
      View All 130 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile